Tirzepatide

Tirzepatide works by mimicking the effects of two hormones and binding to both GLP-1 and GIP receptors, making it a dual-action agonist. When bound to these receptors, the pancreas is signaled to produce insulin which regulates blood sugar. Additionally, gastric emptying is slowed down causing you to feel full for longer and reduce cravings. This combination of glycemic control, and feelings of satiety are the hallmarks of this novel medication.

Tirzepatide offer a range of benefits that make them a powerful tool in the fight against obesity and related health issues:

• Effective Weight Loss: Clinical studies have shown that Tirzepatides can help patients lose a significant percentage of their body weight, often more effectively than other weight loss medications.
• Appetite Suppression: By targeting both GLP-1 and GIP receptors, Tirzepatides help reduce hunger and promote a sense of fullness, making it easier to adhere to a reduced-calorie diet.
• Improved Blood Sugar Control: In addition to promoting weight loss, Tirzepatides are highly effective in managing blood sugar levels, reducing the risk of developing type 2 diabetes or improving control in those already diagnosed.
• Convenient Administration: Tirzepatides are administered as a once-weekly injection, offering a simple and convenient option for those seeking long-term weight management solutions.
• Long-Lasting Results: When used as part of a comprehensive weight loss program, Tirzepatide can help patients achieve and maintain their weight loss goals over the long term.
• Treatment for pre-diabetes (reduction of A1c)

It is typically recommended for individuals with a BMI of 30 or higher, or for those with a BMI of 27 or higher who have obesity-related health conditions. A consultation at Figura Medspa Austin will help determine what medical weight loss medication treatment plan is right for you. Candidacy is determined by medical evaluation. Not every patient is a candidate.

Common side effects include nausea, vomiting, diarrhea, and mild digestive discomfort, which typically decrease over time as your body adjusts to the medication. Our team will monitor your progress and adjust your treatment as needed to minimize side effects.

Many patients begin to see weight loss within the first few weeks of treatment, with more significant results becoming evident over several months. Consistency with the medication and lifestyle changes is key to achieving optimal results.

Tirzepatide and semaglutide are both in the class of drugs known as incretin mimetics but there are some differences between the two. While semaglutide acts only on GLP-1 receptors, tirzepatide acts on both GLP-1 and GIP receptors. Both are effective treatments for weight loss, however responses to these medications may vary depending on the individual. Our licensed medical team will work with you to find the option that is safest and most effective in achieving your weight-loss goals.

Some studies have shown greater weight-loss in participants using tirzepatide vs. semaglutide. However, there are limitations to these studies due to variables like diet, exercise, and diversity of participants. As with all medications, individuals may respond differently so it is important to have options. Our licensed medical professionals are here to tailor your treatment to your needs, achieving the safest and optimal outcome.

Tirzepatide, a novel medication used primarily for the management of type 2 diabetes, stands out for its unique mechanism of action and promising effectiveness. However, one of the most pressing concerns for patients and healthcare providers alike is its high cost. Several factors contribute to the elevated price tag of tirzepatide, beginning with the extensive research and development (R&D) required to bring a new drug to market. Developing a new medication can take over a decade and involves rigorous clinical trials to ensure safety and efficacy. Pharmaceutical companies invest millions of dollars into this process, which leads to the final pricing structure for the drug. Furthermore, the cost of compliance with regulatory standards and potential legal liabilities adds to the overall burden, which companies often recoup through product pricing.

Additionally, tirzepatide’s status as a new and innovative treatment plays a significant role in its pricing. New drugs, especially those with groundbreaking results or unique applications, typically command higher prices due to their novelty and the perceived value they provide. Furthermore, competition in the pharmaceutical market can influence pricing. While tirzepatide offers groundbreaking benefits, there may be fewer alternatives available, allowing pharmaceutical companies to set higher prices without the immediate pressure from competitors. The combination of these factors—high R&D costs, regulatory compliance, and the unique standing of tirzepatide in the marketplace—culminate in the steep price of this promising drug, raising important discussions about affordability and accessibility in healthcare.

We currently provide services only for Texas.

Unfortunately, we cannot issue refunds or accept returns of prescription products for reuse or resale, and all sales are final. However, if you feel we have made an error in the filling of your prescription or delivered by mistake please contact us. Please let our 24/7 customer support agents help you via email at info@figuramedspa.com or call at (512) 400-4213.

Medications for Figura’s weight management program are dispensed by Stonegate Pharmacy LP, a licensed compounding pharmacy located in Austin, Texas. 2501 W William Cannon Dr #203, Austin, TX 78745. (512) 707-2300. Texas State Board of Pharmacy license number 24369. 

Figura Medspa’s weight management program operates under the medical direction of Arthur Abello, MD, Texas Medical License P6939. Prescriptions are issued only after individual medical evaluation, including review of health history and laboratory results, by a licensed provider. Medications are dispensed by a licensed compounding pharmacy for the individual patient. Candidacy is determined by clinical evaluation — not every patient is a candidate.